KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Other Accumulated Expenses (2020 - 2024)

Historic Other Accumulated Expenses for Co-Diagnostics (CODX) over the last 5 years, with Q4 2024 value amounting to $74634.0.

  • Co-Diagnostics' Other Accumulated Expenses rose 18835.14% to $74634.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $74634.0, marking a year-over-year increase of 18835.14%. This contributed to the annual value of $74634.0 for FY2024, which is 18835.14% up from last year.
  • According to the latest figures from Q4 2024, Co-Diagnostics' Other Accumulated Expenses is $74634.0, which was up 18835.14% from $25883.0 recorded in Q4 2023.
  • In the past 5 years, Co-Diagnostics' Other Accumulated Expenses ranged from a high of $894458.0 in Q4 2021 and a low of $25883.0 during Q4 2023
  • In the last 5 years, Co-Diagnostics' Other Accumulated Expenses had a median value of $99020.0 in 2020 and averaged $288072.6.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 80331.04% in 2021, then plummeted by 9252.73% in 2023.
  • Quarter analysis of 5 years shows Co-Diagnostics' Other Accumulated Expenses stood at $99020.0 in 2020, then soared by 803.31% to $894458.0 in 2021, then crashed by 61.28% to $346368.0 in 2022, then tumbled by 92.53% to $25883.0 in 2023, then soared by 188.35% to $74634.0 in 2024.
  • Its Other Accumulated Expenses stands at $74634.0 for Q4 2024, versus $25883.0 for Q4 2023 and $346368.0 for Q4 2022.